Detalles de la búsqueda
1.
The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial.
Lancet
; 403(10436): 1554-1562, 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555928
2.
Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India.
Clin Infect Dis
; 61 Suppl 5: S483-8, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553678
3.
An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia.
Lancet Infect Dis
; 2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38408457
4.
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Hum Vaccin Immunother
; 20(1): 2304974, 2024 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38512394
5.
Post-marketing safety surveillance of the rotavirus vaccine in India.
Vaccine X
; 15: 100362, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37593522
6.
Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure.
Lancet Reg Health Southeast Asia
; 14: 100207, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37492421
7.
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults.
Vaccine
; 41(38): 5614-5621, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532611
8.
Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial.
JAMA Pediatr
; 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37523166
9.
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
Sci Rep
; 13(1): 16579, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37789040
10.
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study.
Lancet Reg Health Southeast Asia
; 10: 100139, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36647543
11.
A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine.
NPJ Vaccines
; 7(1): 170, 2022 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36535976
Resultados
1 -
11
de 11
1
Próxima >
>>